EUPROTEC

euprotec-logo

Euprotec is a collaborative preclinical Contract Research Organisation.

#SimilarOrganizations #Website #More

EUPROTEC

Industry:
Medical

Founded:
2008-01-01

Address:
Manchester, Manchester, United Kingdom

Country:
United Kingdom

Website Url:
http://www.euprotec.com

Total Employee:
501+

Status:
Closed

Contact:
+49 40 560810

Technology used in webpage:
Domain Not Resolving


Similar Organizations

not_available_image

Biomit

Biomit is an innovative clinical research organization.

cynbiose-logo

Cynbiose

Cynbiose is a preclinical Contract Research Organization (CRO).

sacura-logo

Sacura

Sacura is a full-service contract research organization.

Official Site Inspections

http://www.euprotec.com

Unable to get host informations!!!

Loading ...

More informations about "Euprotec" on Search Engine

Evotec Buys Euprotec for Up to $3.15M - genengnews.com

May 28, 2014 Evotec said today it acquired Euprotec, a contract research organization (CRO) specializing in infectious disease and respiratory biology services, in an up-to โ€ฆSee details»

Evotec to Establish an Anti-infectives Platform with the โ€ฆ

May 29, 2014 Evotec AG has announced the acquisition of all shares in Euprotec Ltd, a UK-based specialist contract research organization. Euprotec is a recognized leader in โ€ฆSee details»

Euprotec - Products, Competitors, Financials, โ€ฆ

Euprotec is a specialist contract research organization (CRO) dedicated to the provision of infectious disease, respiratory and allergy biology services. Use the CB Insights Platform โ€ฆSee details»

Euprotec - Crunchbase Company Profile & Funding

Euprotec is a collaborative preclinical Contract Research Organisation. Acquired by. Evotec. Manchester, Manchester, United Kingdom. 501-1000. Private. euprotec.com. โ€ฆSee details»

Evotec - Wikipedia

In 2008, Evotec acquired US-based Renovis in a $152 million stock deal, allowing it to list on the Nasdaq stock exchange. One year later, the company announced it was voluntarily de-listing its American Depositary Receipt to cut costs and concentrate its share trading on the German TecDAX platform. In 2010, the company acquired DeveloGen AG, a spin-out from the Max Planck Institute for Biophysical ChemistrySee details»

Evotec | Forge webcast

Lloyd has >25 yearsโ€™ drug discovery experience and prior to Evotec, was the founding CEO of Euprotec Ltd, a biology CRO dedicated to the delivery of specialist biology services โ€ฆSee details»

Evotec to establish an anti-infectives platform with the โ€ฆ

May 28, 2014 Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive portfolio of assays and disease models, underpinned by โ€ฆSee details»

Evotec Acquires CRO Euprotec To Expand Infectious Disease โ€ฆ

May 30, 2014 Evotec announced in a press release that it has acquired all of the shares of Euprotec, a contract research organization (CRO) based in the UK. Euprotec has a โ€ฆSee details»

Evotec to establish anti-infectives platform with Euprotec โ€ฆ

Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive portfolio of assays and disease models, underpinned by internationally โ€ฆSee details»

Evotec to acquire Euprotec for £1.9m - Manufacturing Chemist

Published: 28-May-2014. Research & Development Finance. Adds capabilities in the area of infectious diseases. Evotec of Germany is to purchase Euprotec, a UK-based specialist โ€ฆSee details»

Evotec acquires anti-infective CRO Euprotec for up to $5m

May 29, 2014 Evotec has acquired all shares in UK-based specialist CRO Euprotec for as much as $5.26m to add anti-infective drug discovery services to its offerings. The โ€ฆSee details»

Evotec completes acquisition of Euprotec to strengthen its anti ...

Euprotec is a recognised leader in anti-infective drug discovery services and its acquisition will strengthen Evotecโ€™s leading position as a fully integrated drug discovery and early โ€ฆSee details»

Evotec to establish an anti- infectives platform with the acquisition ...

Euprotec Ltd, a UK-based specialist contract research organisation. Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive โ€ฆSee details»

Euprotec Ltd | LinkedIn

Euprotec Ltd | 1,374 followers on LinkedIn. Euprotec was acquired by Evotec in 2014. Euprotec is a world leader in the provision of infectious disease biology services and โ€ฆSee details»

Evotec Announces Purchase Of Euprotec - Quick Facts

May 28, 2014 Evotec AG ( EVTCY.PK, EVOTF.PK) Wednesday announced the acquisition of Euprotec Ltd, a UK-based specialist contract research organisation for 1.9 million โ€ฆSee details»

Evotec acquires Euprotec - 2014-05-28 - Crunchbase

May 28, 2014 Euprotec Euprotec is a collaborative preclinical Contract Research Organisation. Acquiring Organization: Evotec Evotec is a pharmaceutical and life โ€ฆSee details»

Euprotec And Cantab Sign Into Novel Antibiotic Partnership

Under the new agreement, Euprotec will assist Cantab in accelerating development of improved therapeutics based on the polymxin core. Polymyxins are a significant class of โ€ฆSee details»

Evotec picks up CRO Cyprotex for $68M | BioPharma Dive

Oct 27, 2016 German drug discovery company Evotec announced Wednesday that it agreed to acquire contract research organization Cyprotex for โ‚ฌ62 million ($67.7 โ€ฆSee details»

Euprotec snapped up by German drug firm - Manchester Evening โ€ฆ

May 28, 2014 Alex Bell. Dr Lloyd Payne, Euprotec chief executive. Biotech firm Euprotec has been sold to a German drug discovery business. Manchester outfit Euprotec was โ€ฆSee details»

Biotechnology Service

Euprotec provides a comprehensive portfolio of infectious disease and respiratory biology services. With a validated portfolio of assays and disease models, underpinned by โ€ฆSee details»